Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab Extension Study in PNH (E07-001)
NCT01194804Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Apr 2008
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 2 trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Alexion Pharmaceuticals. Started Apr 2008; status: completed.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT01194804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194804.